Salmonella typhi vaccine (GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSalmonella typhi vaccine (GlaxoSmithKline)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsTyphoid Fever

Global Approved IndicationsTyphoid Fever

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved Date1998/08/01

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsTyphoid Fever

Inactive IndicationsN/A

ATC CodeJ07AP